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i:10.1016/j.ijsu.2006.09.009Abstract Pylorus-preserving gastrectomy (PPG) is a function-preserving surgical procedure
which is now applied to treat early gastric cancer in the mid-portion of the stomach. We report
a patient who developed a pre-pyloric site gastric cancer after PPG. To our knowledge, this is
the first report on the development of pre-pyloric site gastric cancer after PPG in the English
literature using PubMed.
ª 2006 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.Introduction
Pylorus-preserving gastrectomy (PPG) was first reported as
a new operative procedure for benign gastric disease by
Maki et al. in 1967.1 This technique has the advantages of
reducing postoperative complaints such as Dumping syn-
drome or reflux remnant gastritis. Kodama et al.2 reviewed
154 patients with early gastric cancer occurring in the mid-
portion of the stomach, and concluded that no suprapyloric
lymph node metastasis was observed. Thus, they applied
this surgical technique to treat early gastric cancer located
in the mid-portion of the stomach. A postoperative evalua-
tion study on the function of the remnant stomach and3433 1111; fax: þ81 03 5472
e.jp (A. Shida).
6 Surgical Associates Ltd. Publishnutritional status showed better outcomes in PPG than con-
ventional distal gastrectomy (CDG).3 We herein report
a case with newly developed gastric cancer in a pre-pyloric
portion of remnant stomach after PPG.
Case report
A 64-year-old male had undergone PPG for early gastric
cancer on August 4, 1999. A pyloric lesion 2.5 cm in length
was preserved and anastomosed with proximal remnant
stomach (Fig. 1). Lymphadectomy including Nos. 1, 3, 4sb,
4d, 6 and 7 was undertaken according to the general rules
of the Japanese Gastric Cancer Association. Pathological
diagnosis was well-differentiated adenocarcinoma with
no lymphatic or vessel invasion, and the surgical margins
were negative for cancer cells (Fig. 2). The final stage was
f-IA (pT1(M),pN0,H0,P0,CYX, defined by the general rulesed by Elsevier Ltd. All rights reserved.
Figure 1 Macroscopic view of the stomach at the first
operation. The white arrow indicates the first gastric cancer.
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follow-up included chest radiography, bolus-contrasted
computed tomography and ultrasonography, as well as labo-
ratory tests including carcinoembryonic antigen (CEA) and
carbohydrate antigen 19-9 (CA19-9) every 4 months and
upper gastrointestinal endoscopy annually. Four years after
surgery, he came to our clinic complaining of abdominal dis-
tension. The physical examination exhibited no remarkable
findings, and the serum levels of tumor markers were within
normal limits. However, upper gastrointestinal endoscopyFigure 2 Pathomicroscopic view of the first gastric cancer
which demonstrates well differentiated adenocarcinoma
(H&E stain 100).indicated IIc-type lesion in the pre-pyloric portion
(Fig. 3b). Pathological examination of the biopsy specimens
revealed signet ring cell carcinoma. The newly detected
pre-pyloric gastric cancer was judged to be a residual cancer
in the remnant stomach, but not a recurrence. We then pro-
ceeded with total gastrectomy with D2 lymphadenectomy
and splenectomy on July 30, 2003. We finally decided to per-
form this procedure because the tumor seemed to invade the
muscular propia or deeper, judged intraoperatively, and the
preoperative pathological diagnosis was signet ring cell car-
cinoma, which usually tends to spread into the gastric wall.
Furthermore, we performed sentinel node navigation sur-
gery with the technique of infrared ray electronic endoscopy
combined with indocyamine green injection4 in the submu-
cosal layer around the tumor by using intraoperative gastric
endoscopy. The sentinel node indicated by lymphatic flow
was No. 11, the lymph node located around the splenic ar-
tery. The pathological finding was poorly differentiated ade-
nocarcinoma with signet ring cell carcinoma in greater
curvature of the pre-pyloric region, which was limited to
themucosal layer (Figs. 4, 5). There was no lymphatic or ves-
sel invasion and surgical margins were negative for cancer
cells. The final stage was f-IA (pT1 (M), pN0, H0, P0, CYX).
His postoperative recovery was uneventful, and the patient
remains recurrence-free after 35 months.Discussion
The definition of remnant gastric cancer remains obscure.
In the past, remnant gastric cancer was a cancer which
arose in the remnant stomach 10 or 20 years after surgery
for benign gastric diseases.5 Recently Kaminishi et al.6 pro-
posed to define and classify remnant gastric cancer into
three types: (1) a primary remnant gastric cancer more
than 10 years after surgery regardless of the previous gas-
tric disease; (2) a residual cancer in the remnant stomach
within 10 years after surgery, regardless of whether the
previous disease was benign or cancerous, with cancer-
free resection margin; (3) a recurrent cancer found at the
anastomosis or resection margin in the remnant stomach
within 10 years after surgery for malignancy, or the previ-
ous surgery was a non-curative operation. We finally judged
this case as a residual cancer in the remnant stomach in
accordance with Kaminishi’s criteria for the following
reasons: (1) upper gastrointestinal endoscopy carried out
prior to the first operation indicated no abnormal lesion
in the pre-pyloric portion (Fig. 3a); (2) histological differ-
ences in the resected specimens between the first and
second operations (Figs. 2, 5); (3) remnant gastric cancer
developed within 4 years after surgery; (4) the surgical
margins of the first operation were free of cancer cells.
The pathological finding of the first operation indicated
gastric incomplete-type intestinal metaplasia in the sur-
rounding mucosa of the cancer area with mild atrophic
gastritis and fibrosed submucosa. Likewise, the second
cancer was surrounded by incomplete-type intestinal meta-
plasia with severe atrophic gastritis. Jass7 and Filipe et al.8
reported that incomplete-type intestinal metaplasia was
frequently observed around gastric carcinoma and they sug-
gested that this status has a high malignant potential and
may be a pre-neoplastic condition. Several authors have
Figure 3 Upper gastrointestinal endoscopy view of the pre-pylorus: (A) at the first operation; (B) at the second operation.
e22 A. Shida et al.also reported that there is a pronounced tendency for the
carcinomas to occur in the gastric mucosa with incom-
plete-type intestinal metaplasia in patients with multiple
early gastric carcinomas.9,10 Isozaki et al. reported fre-
quent coexistence of severe dysplastic lesions and mutant
p53 protein expression in the background mucosa of multi-
ple gastric carcinomas.11 These reports and our experience
suggest that coexistence of incomplete-type intestinal
metaplasia around the cancer area will be a risk factor of
residual cancer in the remnant stomach. Therefore we
should refer to the histological condition of the surrounding
mucosa of cancer tissue in deciding on the operative proce-
dure, PPG or CDG.
It is of note that lymph nodes around the splenic artery
were detected as sentinel nodes using infrared rayFigure 4 Macroscopic view of the remnant stomach. The
white arrow indicates the secondary primary gastric cancer,
and the broken line shows the suture line of PPG.electronic endoscopy combined with indocyamine green
injection. Although it was unexpected, we decided to
perform a total gastrectomy and splenectomy with D2
lymph node dissection from this information. In conse-
quence, the cancer was confined within the muscular layer
and there was no lymph node metastasis. However, this
result led to some problems in managing remnant gastric
cancer. Perigastric lymph nodes are usually dissected at the
time of PPG, therefore the cancer possibly metastasizes to
other lymph nodes directly through the network of the
lymphatic system in cases of remnant gastric cancer. Under
conditions where remnant gastric cancer in the pre-pyloric
site following PPG seems to invade deeper than the
submucosal layer, it may be reasonable to proceed to total
gastrectomy with D2 lymph node dissection.
In conclusion, PPG has advantages over CDG in terms of
gallbladder function, the condition of the remnant stom-
ach, and gastric emptying3 and the dumping scores wereFigure 5 Pathomicroscopic view of the remnant gastric can-
cer which demonstrates signet ring cell carcinoma (H&E stain
200).
Pre-pyloric site gastric cancer after pylorus-preserving gastrectomy (PPG) e23significantly lower in the PPG group compared with the CDG
group.12 On the other hand, PPG should be applied carefully
for patients with incomplete-type intestinal metaplasia at
the pre-pyloric site.
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